- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/42 - Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Patent holdings for IPC class C07D 277/42
Total number of patents in this class: 303
10-year publication summary
|
23
|
16
|
15
|
26
|
18
|
18
|
12
|
16
|
16
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19839 |
11 |
| The Board of Trustees of the Leland Stanford Junior University | 6380 |
9 |
| Neurocrine Biosciences, Inc. | 401 |
8 |
| Novartis AG | 10883 |
7 |
| Duke University | 3063 |
7 |
| Cyteir Therapeutics, Inc. | 39 |
7 |
| Ligand Pharmaceuticals Incorporated | 119 |
6 |
| LG Chem, Ltd. | 17564 |
5 |
| Sanofi | 4021 |
5 |
| PIC Therapeutics, Inc. | 12 |
5 |
| Bristol-myers Squibb Company | 4875 |
4 |
| Bayer Cropscience AG | 2057 |
4 |
| Chaperone Therapeutics, Inc | 5 |
4 |
| Dompé Farmaceutici S.p.A. | 268 |
4 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 186 |
4 |
| Shionogi & Co., Ltd. | 867 |
4 |
| ELA Pharma Ltd. | 5 |
4 |
| Janssen Pharmaceutica N.V. | 3413 |
3 |
| Bayer AG | 3308 |
3 |
| Amgen Inc. | 4055 |
3 |
| Other owners | 196 |